Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness is partly caused by specific genes, but most genetic factors are still unknown.

Adalimumab can cause complete hair loss in rare cases.

Most patients with alopecia areata in China have patchy hair loss, with total hair loss being less common, and the condition often starts around age 35 and can negatively affect quality of life, especially in more severe cases.

Melatonin may help treat hair loss and needs more research.

cp-asiAR may effectively treat androgenetic alopecia by promoting hair growth and reducing androgen receptor activity.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

Hair loss caused by genetics and hormones; more research needed for treatments.

Alopecia patients have higher heart disease risk; statins and finasteride may help.

Ludwig pattern hair loss results from varying androgen sensitivity, causing fewer thick hairs and more thin hairs.

Tofacitinib may help treat severe hair loss, but more research is needed.

The document concludes that alopecia areata is an autoimmune disease without a definitive cure, but treatments like corticosteroids are commonly used.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

The document suggests using standardized methods to track and measure hair loss in alopecia areata, including patient self-assessment and a 50% improvement in specific scores as a treatment goal.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Isotretinoin and acitretin may effectively stabilize the hairline in patients with frontal fibrosing alopecia.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Researchers created a new tool to measure the effects of alopecia areata from the patient's view, focusing on hair loss, daily life, and emotional health.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

The main goal for new Alopecia Areata treatments should be significant improvement in scalp hair growth.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Baricitinib, a medication taken by mouth, was effective in regrowing hair for people with severe hair loss.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.

The trial is testing if a helmet that uses light can prevent hair loss during chemotherapy.